- Home
- EVTV vs TPST Comparison
EVTV vs TPST Comparison
Compare EVTV & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTV
- TPST
- Stock Information
- Founded
- EVTV 2012
- TPST 2011
- Country
- EVTV United States
- TPST United States
- Employees
- EVTV N/A
- TPST N/A
- Industry
- EVTV Auto Manufacturing
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- EVTV Consumer Discretionary
- TPST Health Care
- Exchange
- EVTV Nasdaq
- TPST Nasdaq
- Market Cap
- EVTV 24.6M
- TPST 27.2M
- IPO Year
- EVTV 2017
- TPST N/A
- Fundamental
- Price
- EVTV $1.38
- TPST $0.70
- Analyst Decision
- EVTV
- TPST Strong Buy
- Analyst Count
- EVTV 0
- TPST 4
- Target Price
- EVTV N/A
- TPST $20.00
- AVG Volume (30 Days)
- EVTV 61.3K
- TPST 1.4M
- Earning Date
- EVTV 11-14-2024
- TPST 11-12-2024
- Dividend Yield
- EVTV N/A
- TPST N/A
- EPS Growth
- EVTV N/A
- TPST N/A
- EPS
- EVTV N/A
- TPST N/A
- Revenue
- EVTV $1,730,010.00
- TPST N/A
- Revenue This Year
- EVTV N/A
- TPST N/A
- Revenue Next Year
- EVTV N/A
- TPST N/A
- P/E Ratio
- EVTV N/A
- TPST N/A
- Revenue Growth
- EVTV N/A
- TPST N/A
- 52 Week Low
- EVTV $1.06
- TPST $0.70
- 52 Week High
- EVTV $3.20
- TPST $6.00
- Technical
- Relative Strength Index (RSI)
- EVTV 39.46
- TPST 24.08
- Support Level
- EVTV $1.33
- TPST $0.86
- Resistance Level
- EVTV $1.43
- TPST $0.86
- Average True Range (ATR)
- EVTV 0.11
- TPST 0.07
- MACD
- EVTV 0.00
- TPST -0.01
- Stochastic Oscillator
- EVTV 23.81
- TPST 0.00
About EVTV Envirotech Vehicles Inc.
Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.